- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Animal-Free Bionic Matrix Powder, Type VI, Lyophilized |
| Catalog No. | RERE-0115 |
| Description | A type VI member of the bionic matrix powder series, delivered as a lyophilised, component-defined scaffold built from blended bio-based materials. Because the network forms by self-assembly of its own constituents rather than by crosslinking, no cytotoxic crosslinkers are present, and no animal-derived fractions are introduced at any step. Adhesion motifs such as RGD can be covalently incorporated, letting the powder reproduce the material behaviour, microstructure and biological function of natural extracellular matrix and thereby recreate tissue-like growth conditions in vitro. Supplied sterile with no detectable endotoxin or mycoplasma. |
| Intended Use | Recreating tissue-like ECM microenvironments in vitro with a defined, animal-free scaffold |
| Principle / Technology | Self-assembled network formation with optional covalent incorporation of RGD-type adhesion sequences |
| Sample Type | Cell culture models needing chemically defined extracellular scaffolds |
| Specificity | Component-defined; animal-origin free; sterile; endotoxin-free; mycoplasma-free; type VI |
| Reaction Conditions / Protocol | Reconstitute aseptically and introduce into the culture vessel or medium |
| Storage Conditions | 2 to 8°C |
| Package Specifications | 15 mg |
| Key Features | Powder format allows concentration adjustment on reconstitution; type VI variant |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagnoTech. All rights reserved.
